ARK Genomic Revolution ETF vs Dominion Energy Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.37, while Dominion Energy Inc trades at $70.29 (market cap $61.64B). The key difference: Dominion Energy Inc pays a 3.81% dividend while ARK Genomic Revolution ETF pays none, and Dominion Energy Inc is trading nearer its 52-week high, ARK Genomic Revolution ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | D | |
|---|---|---|
Sector | Sector/Thematic | Utilities |
52-Week High | $43.57 | $70.08 |
52-Week Low | $23.09 | $56.55 |
Market Cap | — | $61.64B |
Enterprise Value | — | $114.04B |
Dividend Yield | — | 3.81% |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Dominion Energy (D) trades at $70.08, up 0.91% today, near its consensus price target of $69.50. The stock shows bullish technical signals with strong moving average support and recent earnings beats. Revenue grew to $16.51B in 2025 with net income margin expanding to 18.16%. The pending $66.8B acquisition by NextEra Energy dominates news flow, positioning Dominion as key infrastructure for AI data center power demand.
Investment outlook balances acquisition premium potential against regulatory approval risks. Strong profitability trends and strategic positioning in power infrastructure support upside, but deal uncertainty and high debt levels pose near-term volatility. Wall Street sentiment is cautious with 59% hold ratings, reflecting wait-and-see approach pending merger resolution.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Based in Richmond, Virginia, Dominion Energy is an integrated energy company with over 30 gigawatts of electric generation capacity and more than 90,000 miles of electric transmission and distribution lines. Dominion owns a liquefied natural gas export facility in Maryland and is constructing a 5.2 GW wind farm off the Virginia Beach coast.
Read more on D →